• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Eton Pharmaceuticals, Inc. - Common Stock (NQ:ETON)

    23.54 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 23.54
    Bid (Size) 22.48 (500)
    Ask (Size) 24.98 (800)
    Prev. Close 23.54
    Today's Range 23.54 - 23.54
    52wk Range 13.09 - 27.29
    Shares Outstanding 25,688,062
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Eton Pharmaceuticals Announces CFO Succession Plan
    Experienced pharmaceutical executive Judith M. Matthews to assume CFO role on June 1st 
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eton Pharma (ETON) Earnings Call Transcript ↗
    Eton Pharma (ETON) Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings

    Performance

    YTD
    +44.8%
    +44.8%
    1 Month
    -1.1%
    -1.1%
    3 Month
    +53.3%
    +53.3%
    6 Month
    +26.9%
    +26.9%
    1 Year
    +65.1%
    +65.1%

    More News

    Read More
    Eton Pharmaceuticals (NASDAQ:ETON) Posts Mixed Q4 2025 Results with Revenue Beat and EPS Miss ↗
    Via Chartmill
    News headline image
    Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
    Via Benzinga
    News headline image
    Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eton Pharma (ETON) Q3 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    ETON PHARMACEUTICALS INC (NASDAQ:ETON) Reports Q3 2025 Revenue Beat and EPS Miss ↗
    Via Chartmill
    News headline image
    Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eton (ETON) Q2 Revenue Jumps 108% ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue ↗
    Via Benzinga
    News headline image
    Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
    From Eton Pharmaceuticals
    Via GlobeNewswire
    News headline image
    A Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 Analysts ↗
    Via Benzinga
    News headline image
    Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire

    Frequently Asked Questions

    Is Eton Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Eton Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Eton Pharmaceuticals, Inc. - Common Stock trade on?
    Eton Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Eton Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Eton Pharmaceuticals, Inc. - Common Stock is ETON on the Nasdaq Stock Market
    What is the current price of Eton Pharmaceuticals, Inc. - Common Stock?
    The current price of Eton Pharmaceuticals, Inc. - Common Stock is 23.54
    When was Eton Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Eton Pharmaceuticals, Inc. - Common Stock was at 04/21/26 04:00 PM ET
    What is the market capitalization of Eton Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Eton Pharmaceuticals, Inc. - Common Stock is 604.70M
    How many shares of Eton Pharmaceuticals, Inc. - Common Stock are outstanding?
    Eton Pharmaceuticals, Inc. - Common Stock has 605M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.